MedImmune licenses six investigational projects to new spin-out Viela Bio
MedImmune LLC spun out a new company, Viela Bio, and granted the firm rights to six investigational compounds in development for autoimmune and inflammatory conditions.
- Large Molecule
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
- Reverse Licensing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com